-
Recent Posts
Recent Comments
Archives
- October 2012
- December 2011
- November 2011
- September 2011
- March 2011
- December 2010
- November 2010
- September 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- November 2009
- October 2009
- September 2009
- July 2009
- June 2009
- February 2009
- January 2009
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- February 2007
- December 2006
- November 2006
- October 2006
- August 2006
- April 2006
- March 2006
- December 2005
- November 2005
- July 2005
- March 2005
- February 2005
- January 2005
- December 2004
- November 2004
- October 2004
- September 2004
- August 2004
Categories
Meta
Monthly Archives: September 2008
Antibiotics in pregnancy
Readers may be aware of the recent news story concerning the use of antibiotic in pregnancy. The NPC blog has an informative post with useful links within it on this subject. The prescription of antibiotics for women in spontaneous preterm … Continue reading
Posted in teratogenicity
Comments Off
APRIL conference 2008
Readers may be interested to know that the charity APRIL (Adverse Psychiatric Reactions Information Link) are running a study day on the 6th of November 2008 in London. Adverse psychiatric side effects of medicines: What’s your responsibility? Venue: Friends House, … Continue reading
Posted in Events
Comments Off
Reporting reactions to Human papillomavirus (HPV) vaccine
Readers are reminded that adverse reactions to vaccines can be reported to the Yellow Card Scheme via the Yellow Cards in the BNF, and online. The following is a letter related to the Human papillomavirus (HPV) immunisation programme from the … Continue reading
Posted in MHRA, Yellow Card Scheme
Comments Off
Rituxan (rituximab) and progressive multifocal leukoencephalopathy (PML)
The FDA have posted details of a warning by the manufacturer of rituximab concerning a case report of progressive multifocal leukoencephalopathy: Genentech informed healthcare professionals of revisions to prescribing information for Rituxan regarding a case of progressive multifocal leukoencephalopathy (PML) … Continue reading
Posted in FDA
Comments Off
Drug Safety Update: September 2008
The MHRA have published September’s Drug Safety Update, which includes: Drug safety advice Fentanyl patches: serious and fatal overdose from dosing errors, accidental exposure, and inappropriate use Yellow Card scheme update Please report suspected adverse reactions to vaccines Hot topic … Continue reading
Posted in MHRA
Comments Off